Artificial Vital Organs and Medical Bionics Market Segmented By Artificial Vital Organs, Medical Bionics Type In North America, Latin America, Europe, Asia Pacific, Middle East & Africa Region
Industry: Healthcare
Published Date: May-2022
Format: PPT*, PDF, EXCEL
Delivery Timelines: Contact Sales
Number of Pages: 306
Report ID: PMRREP33106
The artificial vital organs and medical bionics market is anticipated to have a significant CAGR of 8.7% during the period of 2022-2032.
The artificial vital organs and medical bionics market is expected to expand from US$ 46.4 billion in 2022 to US$ 107.4 billion in 2032. Previously, the market grew at a faster rate of 9.6% from 2015 to 2021, culminating in a market of US$ 42.4 billion in 2021.
“Higher demand for artificial vital organs and medical bionics is driven by positive government actions to protect patient safety standards and research activities.”
Over the forecast period, rising prevalence of disorders such as respiratory ailments, heart, cirrhosis, and kidney and liver failures are expected to raise demand for synthetic organs. Furthermore, the unprecedented growth of the senior population, which is especially susceptible to organ ailments, contributes significantly to the artificial vital organs and medical bionics market.
| Attributes | Details |
|---|---|
|
Artificial Vital Organs And Medical Bionics Market CAGR (2022-2032) |
8.7% |
|
Artificial Vital Organs And Medical Bionics Market Size (2022) |
US$ 46.4 billion |
|
Artificial Vital Organs And Medical Bionics Market Size (2032) |
US$ 107.4 billion |
The sudden emergence of the COVID-19 pandemic prompted the imposition of strict lockdown laws in various countries, causing interruptions in Artificial Vital Organ import and export activity. COVID-19 has the potential to affect the global economy in three ways: directly affecting production and demand, disrupting supply chains and marketplaces, and having a financial impact on businesses and financial markets.
The CAGR for artificial vital organs and medical bionics market has dropped from 9.6% between 2015 and 2021 to 8.7% by 2032 as a result of supply chain interruptions.
The shortage of organs and tissues for transplantation, as well as increasing demand for immunosuppressive medications and R & D methods for organ regeneration using modified tissues, are likely to boost artificial vital organs and medical bionics market expansion.
Furthermore, positive government initiatives to maintain patient safety standards are predicted to support artificial vital organs and medical bionics market expansion over the forecast period. Research activities in this field are expected to help artificial vital organs and medical bionics market share.
The demand for artificial organs has been fueled by ongoing research activities, such as the development of artificial organs with increased survival rates and faster patient recovery times. Over the projected period, improvements in the durability and compatibility of organ implants, as well as targeted research on reducing complication rates, are expected to fuel the artificial vital organs and medical bionics market growth.
Over the projected period, the introduction of life-saving technologies, such as the bridge to transplant and bridge to recovery in critical instances, is expected to aid the demand for artificial vital organs and medical bionics market.
High gadget and surgery costs, a scarcity of surgical skills, and uncertain reimbursement rules in some places are all limiting the artificial vital organs and medical bionics market growth.
Furthermore, an artificial heart transplant may result in death or crippling damage, which is projected to hinder market growth. The artificial vital organs and medical bionics market is expected to be hampered by the high cost of artificial organs and the lengthy approval procedure.
The demand for artificial organs and the bionics business is growing in tandem with the demand for organ donors. Progress in the field of 3D bioprinting has been proven to be crucial in organ transplantation, as it is used to improve artificial organs.
3D bioprinting has a higher demand than traditional bioprinting, since it reduces the chances of organ refusal. Advanced biomaterials in artificial organs, as well as lucrative potential in emerging nations, are likely to generate considerable opportunity for artificial vital organs and medical bionics market producers.
| Attributes | Artificial Vital Organs And Medical Bionics Market |
|---|---|
|
CAGR (2022-2032) |
8.7% |
|
Market Value (2026) |
US$ 64.34 billion |
|
Growth Factor |
Ongoing research activities, such as the development of bioartificial organs with increased survival rates, are driving the market growth. |
|
Opportunity |
R & D methods for organ regeneration using modified tissues expand the market's prospects. |
|
Key Trends |
Advanced biomaterials in artificial organs, as well as lucrative potential in emerging nations, are creating a higher scope for the market. |
| Attributes | Medical Bionic Implant /Artificial Organs Market |
|---|---|
|
CAGR (2022-2032) |
7.1% |
|
Market Value (2026) |
US$ 33.04 billion |
|
Growth Factor |
Due to new and improved technology, as well as increased organ failure due to aging and age-related illnesses, the market is expected to be considerable. |
|
Opportunity |
In growing economies, rising healthcare expenditures and the introduction of new healthcare facilities create economic potential. |
|
Key Trends |
The increase in the number of patients waiting for organ transplants is expected to boost the market forward. |
| Attributes | Non-Surgical Bio-Implants Market |
|---|---|
|
CAGR (2022-2032) |
8.2% |
|
Market Value (2026) |
US$ 175.1 billion |
|
Growth Factor |
The market is growing owing to technical developments and increased awareness about the success of cosmetic implantations. |
|
Opportunity |
Due to the rising prevalence of cardiovascular and orthopedic disorders, cardiac pacemakers and orthopedic artificial implants are in high demand, providing appealing business opportunities |
|
Key Trends |
Dental implants are a major contributor to the bio-implant market's expansion. |
Organ transplantation has become routine practice due to significant advancements in healthcare technology. Patients have a high need for organ transplant operations, but the number of donors available to meet this demand is limited. Demand for artificial vital organs and medical bionics is growing as a result of this widening gap.
Furthermore, the availability of sophisticated artificial support systems, as well as the expansion of healthcare facilities, are expected to support the artificial vital organs and medical bionics market share.
Primarily, the world's growing senior population is driving demand for organ implants. The number of people over the age of 65 who are looking for and receiving organ transplants is increasing. As they are more susceptible to post-transplant malignancies, artificial devices are in high demand, boosting the artificial vital organs and medical bionics market growth.
Increasing awareness about public and private reimbursement policy coverages, as well as government efforts to launch universal health coverage schemes, are some trends expected to boost adoption rates and create opportunities for global artificial vital organs and medical bionics market players during the forecast period.
Anyone considering or undergoing an organ transplant faces numerous significant hurdles. Artificial vital organs and medical bionics market growth is hampered by the availability of organs and donors, which is not always successful, and the fundamental problem of finding a proper match for replacement.
These artificial vital organs and medical bionics market dynamics variables include the drivers, opportunities, restraints, and challenges, as well as the impact of these factors on the market. The drivers and limits are intrinsic to the artificial vital organs and medical bionics market, while the possibilities and difficulties are extrinsic. The artificial vital organs and medical bionics market outlook projects revenue growth throughout the forecast period.
Artificial vital organs and medical bionics market is segmented into type and region.
According to FMI, the artificial vital organs sector held the biggest market share in the artificial vital organs and medical bionics market, and is predicted to have a CAGR of 8.2% over the forecast period, preserving its dominant position. Rapid technical breakthroughs and a large number of unmet needs are two major drivers driving artificial vital organs and medical bionics market expansion.
Furthermore, increased patient acceptability of medical bionics is likely to increase. Over the projection period, constant breakthroughs in the fields of medical research and biomedical engineering are predicted to enhance the adoption rate of synthetic organs.
| Regions | CAGR (2022-2032) |
|---|---|
|
United States |
8.5% |
|
United Kingdom |
7.8% |
|
China |
8.2% |
|
Japan |
7.2% |
|
South Korea |
6.4% |
North America Outlook
Owing to the increasing acceptance of artificial organs in emerging markets, North America was recognized as the largest regional category, with an expected market share of US$ 38.3 billion and a CAGR of 7.5% during the forecast period 2022-2032. Furthermore, with a low rate of cadaveric organ donation, artificial organ transplants are projected to become necessary. The business is likely to be driven by large private sector expenditures and a rising number of new product approvals linked to optimal exploitation of innovative transplants.
Asia Pacific Outlook
Due to rising income levels, government initiatives, increased healthcare awareness, and high healthcare expenditure, Asia-Pacific is emerging as the fastest expanding market for artificial vital organs and medical bionics.
The Asia Pacific market is expected to grow at the fastest rate during the period of the forecast, thanks to developing nations such as China and Japan, with the expected CAGR of 8.2% and 7.2% through 2032.
These countries have a large population base and a higher incidence of chronic illnesses. The increase in the number of chronic illnesses that cause organ failure is expected to boost market growth.
Europe Outlook
During the forecast period, the significant gain in revenue share is expected in Europe, followed by Asia Pacific. The UK is expected to have a CAGR of 7.8% during the forecast period. High levels of awareness about new technologies entering the market and bettering healthcare infrastructure are projected to boost the artificial vital organs and medical bionics market growth.
The artificial vital organs and medical bionics market players develop an array of products, which cater to the needs of numerous surgical applications, such as cardiovascular disorders and organ failures.
The majority of artificial vital organs and medical bionics market competition is built on delivering innovative and efficient services. The data shows how rivals earn from the market for artificial vital organs and medical bionics.
Key business strategies adopted by these players include collaboration with research organizations and hospitals to enhance the quality, and effectively commercialize the products with an aim to acquire global expansion.
By Type
By Region
To know more about delivery timeline for this report Contact Sales
The artificial vital organs and medical bionics market is projected to have a CAGR of 8.7% during the forecast period.
The U.S. is the leading country, with an anticipated CAGR of 8.5% through 2032.
Artificial vital organs lead the market with the projected CAGR of 8.2% through 2032.
The artificial vital organs and medical bionics market is predicted to grow to US$ 107.4 billion by 2032.
Europe is the leading region, with an anticipated CAGR of 7.8% through 2032.
